Jin Medical International (ZJYL) Equity Ratio (2022 - 2025)
Jin Medical International (ZJYL) has disclosed Equity Ratio for 4 consecutive years, with 0.06 as the latest value for Q3 2025.
- Quarterly Equity Ratio fell 91.11% to 0.06 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.06 through Sep 2025, down 91.11% year-over-year, with the annual reading at 0.06 for FY2025, 91.11% down from the prior year.
- Equity Ratio hit 0.06 in Q3 2025 for Jin Medical International, down from 0.62 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.73 in Q3 2023 to a low of 0.06 in Q3 2025.
- Historically, Equity Ratio has averaged 0.53 across 4 years, with a median of 0.68 in 2022.
- Biggest five-year swings in Equity Ratio: increased 0.16% in 2023 and later crashed 91.11% in 2025.
- Year by year, Equity Ratio stood at 0.73 in 2022, then rose by 0.16% to 0.73 in 2023, then fell by 14.46% to 0.62 in 2024, then plummeted by 91.11% to 0.06 in 2025.
- Business Quant data shows Equity Ratio for ZJYL at 0.06 in Q3 2025, 0.62 in Q3 2024, and 0.73 in Q3 2023.